This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          April 21, 2015

Home  |   About ASHI  |   Education  |   Publications  |   Meetings  |   Careers  |   News  |   Lab Center


Proficiency Testing
Click here to place your 2015 Proficiency Testing order or to view your previous Performance and Summary reports.

Renew Your Membership Now!
It's not too late to renew your ASHI membership. If you haven't received your second dues renewal notice, please contact the ASHI central office at info@ashi-hla.org.

ASHI U
Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
 


ASSOCIATION NEWS


It's Medical Laboratory Professionals Week!
It's time to honor the more than 300,000 medical laboratory professionals around the country for their hard work and dedication to the field. ASHI is celebrating our members who play a vital role in optimizing patient care. Because they often work behind the scenes, few people know about the critical testing laboratory professionals perform each day.

The poster to the right was mailed to ASHI-accredited labs as a way for them to show their pride in being ASHI-accredited. If you are working in an ASHI-accredited lab, feel free to download this poster as a virtual badge you can display on your Facebook page and in your email signature, so that your peers know you are part of ASHI.

Check the ASHI Facebook page for exciting Lab Week events!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Call for ASHI Award Nominations — DEADLINE JUNE 1, 2015
Nominate yourself today for the ASHI Rising Star Award!

AWARD RECOGNIZES REQUIREMENTS
ASHI RISING STAR AWARD An outstanding HLA technologist who has worked in the field fewer than three years and desires to pursue a career in HLA *Short essay* of fewer than four pages describing his/her current work in HLA and why he/she is interested in pursuing a career in HLA

*Essay must be written by the nominee and validated by his/her Lab Director

Also open for nominations: the ASHI Distinguished Service and ASHI Distinguished Scientist Awards!

The ASHI Distinguished Service Award was established in 1999 to honor colleagues who have contributed significantly to ASHI's heritage.

AWARD RECOGNIZES REQUIREMENTS
ASHI DISTINGUISHED SERVICE AWARD ASHI membership past or present, doctoral or non-doctoral. Creativity in moving ASHI in new directions, scientifically and as an organization

Service to ASHI

Educational contribution on behalf of ASHI

Other extraordinary contributions (please explain)
*Letter of nomination from an ASHI member

*Two additional supporting letters

*Candidate's curriculum vitae

The ASHI Distinguished Scientist Award was established in 2001 to honor a distinguished scientist who is an ASHI member. This individual must have contributed significantly to the field of immunogenetics and/or transplant immunology.

AWARD RECOGNIZES REQUIREMENTS
ASHI DISTINGUISHED SCIENTIST AWARD *ASHI membership past or present, doctoral or non-doctoral

*Professional scientific accomplishments: theoretical and technical creativity

*Special contributions and achievements in their field of expertise

*Other extraordinary contributions (please explain)
*Letter of nomination from an ASHI member

*Two additional supporting letters

*Candidate's curriculum vitae

Don't wait! Submit your nominations now! Send nominations and supporting information to: Katherine Miranda
ASHI Executive Office
kmiranda@ahint.com

To view former award winners, please click here.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


MISSED AN ISSUE OF ASHI INSIGHTS?
Click here
to visit the ASHI Insights archive page.


Have you taken ASHI's Technologist Survey yet?
The ASHI Technologist Affairs Committee is conducting a survey of all HLA technologists in North America. This survey is completely anonymous and consists of general questions from location and gender to more specific questions like salary information and compensation for on-call pay. Please take time to thoughtfully answer each question and feel free to add any comments or other information at the end of the survey. Our goal is for each North American HLA technologist to have the opportunity to take this survey, so if someone in your lab did not receive the survey, please forward this email to them. Once the survey results are tabulated, the summary will be made available on the ASHI website inside the member's only section.

The ASHI Technologist Affairs Committee wants to thank you in advance for your participation in this important survey!!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


EDUCATION


2015 Banff-CST Joint Scientific Meeting
The Canadian Society of Transplantation and The Banff Foundation of Allograft Pathology are pleased to co-host the 2015 Banff-CST Joint Scientific Meeting to be held in Vancouver, B.C. from Oct. 5 to 10, 2015. This meeting is a first of its kind in bringing together the international transplantation community, including clinicians, pathologists, immunogeneticists, basic scientists, allied health care colleagues, and policy makers. We anticipate an overall attendance of 600 participants during the meeting and look forward to seeing you in October! More information about the meeting may be found at: http://www.cst-transplant.ca/meetings_asm.html.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Best practices in kidney waitlist management with the new kidney allocation system
The Organ Donation & Transplantation Alliance invites you to attend their next webinar to learn about best practices for efficient and effective management of patients on the kidney waitlist within the context of the new kidney allocation system (KAS) on Tuesday, April 28, 2015 — 3-4pm ET

Speakers: Andrea Tietjen, MBA, CPA, Director of Transplant Finance and Data, Barnabas Health Renal & Pancreas Transplant, Livingston, NJ

John J. Friedewald, MD, Associate Professor of Medicine & Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL

Click here to register for this webinar.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


INDUSTRY NEWS


Hematopoietic stem-cell transplantation may increase risk of fractures
2 Minute Medicine
The use of hematopoietic stem-cell transplantation (HSCTs) has significantly improved survival in patients with multiple myeloma and other hematologic malignancies. Bone loss is a known sequelae of HSCT, potentially leading to pathological fractures contributing to significant disability and worsening quality of life. However, the current incidence and risk factors associated with fractures post-HSCT remains unclear. The purpose of this study was to evaluate the incidence of fractures in post-HSCT patients and to identify potential risk factors for fractures.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HLA-A, B and DRB1 genetic heterogeneity in Quebec
International Journal of Immunogenetics
Recent studies have shown that under specific conditions such as high sample sizes and Hardy–Weinberg equilibrium, bone marrow donor registry data can be used to describe HLA molecular variation across a specific geographic area, thus providing excellent data sets to infer human migrations history. The province of Quebec is known to have experienced a complex history of settlement, characterized by multiple migrations and demographic changes. We thus analysed the data of more than 13000 unrelated individuals acting as volunteer bone marrow donors who were molecularly typed for HLA-A, B and DRB1 polymorphisms in the Héma-Quebec registry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Genes may make 'placebo effect' stronger for some, study says
HealthDay News
A new report suggests that the strength of your "placebo effect" may depend on your particular DNA. In clinical trials of new drugs, people who receive a fake treatment, or placebo, often feel relief from medical conditions and pain. A better understanding of this phenomenon — called the placebo effect — could improve medical research and health care, the authors of the new paper said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASHI Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671  
Contribute news


Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of ASHI Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 7, 2015
March 24, 2015
March 10, 2015





7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063